Backlog Converts Faster, but the Margin Recovery Fails Its Test
Key Takeaways
- The revenue thesis cleared its bar; the profit thesis did not. Organic growth of 16% exceeded the roughly 10% guide, but enterprise adjusted operating margin fell 40 basis points against the roughly 50-basis-point expansion on which July's upgrade depended.
- The EPS beat is smaller after tax timing. Adjusted EPS of $4.86 includes a $0.10 benefit that reverses in Q4; full-year EPS guidance stays at $15.20–$15.30 despite a two-point revenue-growth upgrade.
- The order book still supports a growing business. Backlog reached $12.5 billion, with over $8 billion for 2027 and beyond, while Americas applied revenue grew more than 60%. Supply constraints and weak price realization are making that growth more expensive.
- Rating: Downgrading to Hold from Outperform. Our FY27 adjusted EPS estimate falls to $17.00 from $17.50 and twelve-month value to $459 from $508; roughly 7% prospective total return offers insufficient compensation for a delayed margin recovery.
Results vs. Consensus
| Q3 FY2026 metric | Actual | Consensus | Beat / miss |
|---|---|---|---|
| Revenue | $6,759.7M | $6,500M | Beat: $259.7M / 4.0% |
| Adjusted continuing EPS | $4.86 | $4.73 | Beat: $0.13 / 2.7% |
| GAAP continuing EPS | $4.79 | n/a | n/a |
| GAAP operating income | $1,343.1M | n/a | n/a |
| Gross margin, calculated | 35.28% | n/a | n/a |
| Q3 company-defined FCF, derived | $1,224.8M | n/a | n/a |
Year-over-year financial comparison
| $M except EPS, shares and margins | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | 6,759.7 | 5,742.5 | +17.7% |
| Cost of goods sold | 4,374.9 | 3,624.3 | +20.7% |
| Gross profit, calculated | 2,384.8 | 2,118.2 | +12.6% |
| Gross margin, calculated | 35.28% | 36.89% | -161 bps |
| Selling and administrative expense | 1,041.7 | 952.9 | +9.3% |
| GAAP operating income | 1,343.1 | 1,165.3 | +15.3% |
| Adjusted operating income | 1,363.8 | 1,182.0 | +15.4% |
| Adjusted operating margin | 20.2% | 20.6% | -40 bps |
| GAAP continuing earnings attributable to TT | 1,060.1 | 857.0 | +23.7% |
| GAAP continuing EPS | $4.79 | $3.82 | +25.4% |
| Adjusted continuing EPS | $4.86 | $3.88 | +25.3% |
| Diluted shares, millions | 221.4 | 224.4 | -1.3% |
Sequential comparison
| $M except EPS and margins | Q3 2026 | Q2 2026 | QoQ change |
|---|---|---|---|
| Revenue | 6,759.7 | 6,353.5 | +6.4% |
| Gross profit, calculated | 2,384.8 | 2,259.7 | +5.5% |
| Gross margin, calculated | 35.28% | 35.57% | -29 bps |
| GAAP operating income | 1,343.1 | 1,224.3 | +9.7% |
| Adjusted operating income | 1,363.8 | 1,252.7 | +8.9% |
| Adjusted operating margin | 20.2% | 19.7% | +50 bps |
| Adjusted continuing EPS | $4.86 | $4.31 | +12.8% |
| Bookings | 7,248 | 7,818 | -7.3% |
The sequential operating-margin improvement is real, but July’s commitment was expansion year over year. It is therefore a failed signpost even though Americas achieved its own 50-basis-point improvement. Gross-margin deterioration narrowed from about 203 basis points in Q2 to 161 in Q3, meeting the narrower test of moderation, but gross margin still fell sequentially as production costs outgrew sales.
Quality of the beat
Revenue: The growth is predominantly organic and has a visible operating mechanism: Americas applied equipment revenue grew more than 60%, residential roughly 20%, and transport returned to growth. That is stronger evidence of backlog conversion than another bookings record. Organic growth includes product-transition mix as well as units; the residential refrigerant change is recorded in volume, so 20% growth should not be read as a 20% unit increase.
Margins: Reported incremental adjusted operating margin was 17.9%, calculated from $181.8 million of additional profit on $1,017.2 million of additional sales. Gross profit rose 12.6% while sales rose 17.7%; slower SG&A growth cushioned the damage. This is a business gaining throughput without yet recovering its cost economics, which is why the revenue beat does not restore our prior confidence in FY27 margins.
EPS: The $0.13 consensus beat includes a $0.10 tax-timing benefit. Removing that benefit leaves $4.76, only $0.03 above consensus and $0.06 above the company’s approximately $4.70 guide. The adjusted tax rate fell to 17.3% from 21.3% a year earlier, and a 1.3% reduction in diluted shares also helped EPS outrun operating profit. The timing benefit is not the whole year-over-year tax improvement, and it contributes nothing to full-year guidance because it reverses in Q4.
The GAAP-to-adjusted continuing EPS bridge is $4.79 plus $0.07. Pretax adjustments total $20.7 million, chiefly $16.3 million of acquired-backlog amortization, plus restructuring and transaction costs. Those acquisition costs explain the difference between accounting bases; they do not remove the ongoing supply-chain, pricing and integration burden inside adjusted earnings.
Segment Performance
| Q3 FY2026 ($M) | Revenue | Organic revenue growth | Organic bookings growth | Adj. operating income | Adj. margin / YoY |
|---|---|---|---|---|---|
| Americas | 5,647.9 | 19% | 16% | 1,257.9 | 22.3% / +50 bps |
| EMEA | 755.8 | 2% | 41% | 129.6 | 17.2% / -250 bps |
| Asia Pacific | 356.0 | 7% | 21% | 66.2 | 18.6% / -390 bps |
| Corporate | n/a | n/a | n/a | (89.9) | n/a |
| Total | 6,759.7 | 16% | 20% | 1,363.8 | 20.2% / -40 bps |
Americas: conversion is no longer the uncertainty
Americas supplies approximately 84% of enterprise sales. Commercial HVAC organic revenue grew in the low twenties, applied revenue more than 60%, and services 10%. Residential and transport also contributed, weakening the claim that only data centers can generate growth. The segment’s 22.3% adjusted margin demonstrates that volume absorption can overcome part of the input-cost pressure.
Assessment: The franchise and backlog-conversion pillars remain on track. Yet $239.9 million of additional Americas adjusted profit was partly absorbed by lower EMEA and Asia profit and higher corporate expense. A strong dominant segment does not guarantee the enterprise margin recovery required to justify a premium valuation.
EMEA: orders recover faster than profits
Organic bookings rose 41%, with book-to-bill of 147%, while organic revenue rose only 2%. Excluding the Middle East, management described bookings growth above 50% and high-single-digit revenue growth. The $18.3 million decline in adjusted operating income is economically more useful than the margin percentage alone: the CFO attributed over 80% of the region’s operating-income deterioration to the Middle East conflict.
Assessment: This is consistent with the regional shock already allowed for in July, rather than a fresh collapse in European demand. The improvement to 17.2% margin from Q2’s 13.1% supports the cost-action case, but the 250-basis-point year-over-year decline shows that those actions have not restored the earnings base. Strong orders improve next year’s revenue visibility without establishing when regional profitability normalizes.
Asia Pacific: growth outside China masks a pricing problem
Revenue rose 7% organically, but adjusted operating profit fell to $66.2 million from $74.2 million. China now represents roughly one third of the region; outside China, bookings rose about 70% and revenue grew in the high teens. Regional pricing was down around one point, which management attributed to China.
Assessment: The geographic expansion argument survives, but Q2’s modest margin decline has become a 390-basis-point decline. Asia remains small at roughly 5% of enterprise sales; it cannot overturn the Americas demand story, yet it is now another reason not to assume uniform margin recovery across the portfolio.
Key KPIs
| Operating indicator | Q3 2026 | Q2 2026 | Investment consequence |
|---|---|---|---|
| Enterprise backlog | $12.5B | $12.1B | +73% YoY; continued visibility |
| Backlog for 2027 and beyond | Over $8B | About $6B | Larger future-year allocation, not all next-year sales |
| Enterprise book-to-bill | 107% | 123% | Above one despite faster shipments |
| Organic bookings growth | 20% | 37% | Slower growth, still broad across regions |
| Americas applied revenue growth | Over 60% | Over 40% | Conversion exceeds prior H2 expectation |
| Working capital / annualized revenue | 0.3% | 0.9% | Cash release supports deployment |
Key Topics & Management Commentary
Overall Management Tone: Management remained confident on demand but spent more of the call defending the path from growth to profit. July’s substantial earnings raise has given way to explanations of weaker pricing and supply disruption; the specificity of those explanations is useful, but confidence in the long-term framework is no substitute for delivery against the next quarter’s commitments.
1. More revenue no longer produces a higher earnings guide
“We now expect organic leverage to land in the low 20s, an adjustment from our prior expectation at 25%+, primarily due to the updated price expectation and near-term supply chain and inflationary headwinds, all of which we are actively managing.”
— Chris Kuehn, EVP and CFO
The cut to organic leverage formalizes the risk we highlighted in July. Full-year price realization is now approximately one point, down from the prior 1.5-point expectation. Q3 pricing was only about half a point at enterprise level, with short-cycle incentives, large-fleet mix and China pricing all contributing. This is not evidence of an applied-equipment price collapse, but it means the portfolio is realizing less revenue per unit of cost than planned.
Assessment: The full-year EPS guide needs more sales to deliver the same profit. That deterioration matters more to our FY27 estimate than the modest headline EPS beat, and it removes the margin-of-safety premise behind July’s upgrade.
2. Domestic assembly did not isolate the lower-tier supply chain
“As we ramp up demand on our suppliers, specifically around fans, coils, heat exchangers, we're putting a lot of demand on our supply partners. And obviously, they're trying to expand their capacity. We're working with them, helping them become great lean operators, but it is putting stress on them. I think that's going to continue. I know that will continue in the fourth quarter. We'll see that get better as we work through the first half of 2027.”
— David Regnery, Chair and CEO
Separately, management described a lower-tier capacitor supplier affected by the UFLPA list, interrupting motor and drive deliveries. Several plants ran incomplete products down their lines and later reworked them. The CEO said that rework was 80% complete at quarter-end and entirely complete by the call. Ordinary capacity shortages, however, remain a different problem and persist into early 2027.
Assessment: The in-region manufacturing pillar remains at risk. Domestic final assembly can reduce direct tariff exposure without insulating imported components several tiers below the plant. Removing the one-time rework burden supports a Q4 rebound, but assuming all supply costs disappear would overstate the recovery.
3. A larger future backlog is not a one-year revenue guarantee
“Remember, our backlog is equipment only, so there's no services in that number.”
— David Regnery, Chair and CEO
The CFO later clarified that more than $1 billion could already relate to 2028. The equipment backlog excludes services, which is positive for the total revenue opportunity but makes a simple backlog-to-sales comparison incomplete. Global applied bookings grew over 40%; Americas commercial HVAC bookings rose in the low double digits. Those are different scopes from July’s Americas applied bookings statistic and should not be treated as a single continuous growth series.
Assessment: Slower enterprise order growth from 37% organic to 20% does not establish demand exhaustion when book-to-bill remains above one in every region and shipments are accelerating. The backlog supports continued growth; its duration, customer concentration and undisclosed cancellation terms still argue against capitalizing every dollar as firm FY27 revenue.
4. Services remains the stabilizer, not an immediate cure for mix
“If you took the Middle East out of our number, our service business on a global basis was over 10% again. If you go back, I think we're back to 2020, I was quoting numbers where our compound annual growth rate is in that low teens rate. So this is a very strong, very dependable engine that we have in our company, and it represents approximately a third of our revenues.”
— David Regnery, Chair and CEO
The expanding installed base should generate future maintenance demand, but a quarter dominated by rapid equipment deliveries need not carry the same mix as a mature service portfolio. Management is investing in technician development, including more than 350 apprentices in a four-year program. That is capacity for future service growth, not an immediate supply of fully trained technicians.
Assessment: The services pillar remains on track and reduces the cyclicality of the revenue base. We still lack a separately disclosed data-center service attach rate or profit contribution, so our forecast includes continued service growth without a new service-margin premium.
5. Residential and transport broaden demand but dilute price realization
Residential bookings and organic revenue rose approximately 20%; management denied pull-forward and said year-to-date sell-in and sell-through remained roughly equal. The refrigerant transition’s high-single-digit product price uplift is classified in volume, while channel incentives reduce reported pricing. Those distinctions make the strong sales result credible without making it a pure unit-demand signal.
Transport bookings grew in the high thirties and revenue grew in the high single digits in the prepared remarks; the CFO subsequently described Americas Thermo King revenue growth around 10%. Larger fleets are buying first, improving volumes but producing less favorable price mix. Management expects a robust 2027 recovery while questioning whether trailer manufacturers could support the roughly 28% market growth cited in the call.
Assessment: July’s transport recovery has begun to acquire operating evidence, and residential channel balance remains intact. These developments keep the narrow-growth risk contained. They also explain why revenue breadth and margin weakness can coexist: recovering large customers and incentive thresholds can lower realized price even in a healthy demand quarter.
6. Stellar and new thermal designs extend the opportunity, with investment first
“The fundamental theme of modular designs and the need for modular chiller plants on job sites remains very, very strong. We're putting the investments in place to be ready for a couple of years right now to make it a billion-dollar revenue business with mid-teens EBITDA.”
— Chris Kuehn, EVP and CFO
Stellar’s approximately $500 million FY26 revenue and neutral EPS contribution are unchanged. Florida investment and the commissioning of a Texas factory prepare the business for a roughly $1 billion revenue ambition over the next couple of years. Management described 800-volt direct-current demonstrations and modular reference designs as ways to participate in customers’ thermal-system decisions before equipment procurement.
Assessment: The strategic position is attractive, but reference designs are not a disclosed dollar order book and a future mid-teens EBITDA margin is not current EPS accretion. Our FY27 forecast allows growth and continuing investment; it does not assume Stellar reaches its mature economics next year.
7. Cash conversion strengthens while the liability question changes
| $M unless stated | Nine months 2026 | Nine months 2025 |
|---|---|---|
| Continuing operating cash flow | 3,060.1 | 2,054.1 |
| Capital expenditure | 264.2 | 277.2 |
| Company-defined free cash flow | 2,827.5 | 1,786.0 |
| Adjusted continuing net earnings | 2,620.1 | 2,297.1 |
| FCF / adjusted net earnings, calculated | 107.9% | 77.8% |
| Repurchases settled | 1,338.5 | 1,250.0 |
Q3 free cash flow was $1,224.8 million, derived from the nine-month figure less $1,602.7 million in H1. Company-defined FCF adds back restructuring and transaction cash costs; continuing operating cash flow less capex alone was $2,795.9 million year to date. The cash strength is substantial on either basis.
July’s concern about the accrued-liability build needs updating: that balance declined $366.0 million in Q3 to $4,355.7 million, even while cash generation remained strong. Receivable days improved to 55.2 from 57.3 a year earlier, inventory turns rose to 6.7 from 6.2, and payable days increased to 64.7 from 60.3. The cash-flow line combining working-capital movements and other noncash items improved $719.8 million year over year; it does not isolate customer advances.
Assessment: Cash execution is better than the earnings-margin story, and a continuous accrued-liability build is no longer a sufficient explanation. Some benefit comes from working-capital timing and supplier funding, so we retain a normalization allowance instead of extrapolating 60% cash-flow growth.
8. Buybacks accelerate; acquisitions aim at a production bottleneck
Settled repurchases in Q3 were $582.1 million, calculated from $1,338.5 million year to date less $756.4 million in H1. That exceeds the first-half quarterly average of $378.2 million and meets our prior signpost for a faster pace. Capital deployed or committed through October reached roughly $3.4 billion, including about $930 million of dividends, $1.08 billion of M&A and $1.4 billion of repurchases; commitments and cash settlements have different timing.
The proposed Cancoil acquisition brings a long-standing coil and heat-transfer supplier into the group. It is expected to close in late 2026 or early 2027.
“We represented roughly 40% of the volume, so we're already a major player for them. So us bringing that in-house is a big benefit. Think of these as very large coils that go into large air handlers and large air-cooled chillers. So this really does help solve one of our core component issues from a supply chain perspective.”
— Donny Simmons, EVP and COO
Assessment: Cancoil addresses a specific supply constraint and adds heat-transfer capability, but its expected late-2026 or early-2027 close means the acquisition cannot explain Q3’s margin outcome. Lower capex guidance of approximately 2% of revenue helps near-term cash; the investment case still requires adequate capacity spending, rather than cash generation achieved by indefinitely delaying expansion.
Guidance & Outlook
| FY2026 metric | Prior outlook | October outlook | Assessment |
|---|---|---|---|
| Organic revenue growth | About 9% | About 11% | Raised |
| Reported revenue growth | About 11.5% | About 13.5% | Raised |
| Adjusted continuing EPS | $15.20–$15.30 | $15.20–$15.30 | Unchanged |
| GAAP continuing EPS | $15.00–$15.10 | $15.00–$15.10 | Unchanged |
| Organic operating leverage | 25%+ | Low twenties | Lowered |
| Capital expenditure / revenue | 2–3% | About 2% | Lowered |
| Capital deployment | $2.8–$3.3B | More than $3.4B | Raised |
For Q4, management expects mid-teens organic revenue growth and adjusted EPS of approximately $3.40–$3.50. Price is expected to improve to about 1.5 points at enterprise level and approach two points in Americas, with organic leverage above the long-term 25% threshold. Residential growth is expected in the high single digits. Formal FY27 guidance waits until the Q4 call.
The EPS bridge explains why the unchanged year is not reassuring. Reported nine-month adjusted EPS of $11.79 leaves $3.46 to reach the $15.25 midpoint. July’s rounded quarterly figures implied roughly $3.61 for Q4. About $0.10 of that apparent reduction is tax moving from Q4 into Q3; the remaining roughly $0.05–$0.06 reflects a weaker residual earnings outlook despite a higher revenue plan. Summing individually rounded quarter EPS differs by a cent from the nine-month figure, so the bridge is approximate.
Assessment: Management has reduced the profit hurdle while raising the sales hurdle. Removal of rework, easier price comparisons and transport absorption support the Q4 leverage improvement, but the persistence of ordinary supply shortages argues for a gradual FY27 margin recovery rather than a clean January reset.
Analyst Q&A Highlights
What actually improves in Q4?
Q: “Just trying to understand the drivers of that and how sustainable that rate is as we look into early next year. I realize the comp was very easy from the resi headwinds in Q4 last year. Is that what is helping it or a one-time catch up on the component shortage reversing? Just trying to understand how you are thinking about that organic operating leverage driving Q4 and then beyond.”
— Julian Mitchell, JPMorgan
A: “The comps are easier in the fourth quarter. When we think about the third quarter, leverage last year was actually over 50%. So a tough comp in the third quarter, but it sequentially gets better in the fourth quarter, a little bit easier comps on price. We have announced a number of price increases this year, and that continues to stick. Dave described some of the challenges around supply chain in the third quarter that are behind us now. So that is not carrying over into the fourth quarter.”
— Chris Kuehn, EVP and CFO
Assessment: The answer identifies real near-term drivers, but the resolved disruption is not the entire supply problem. An easier comparison can restore the growth rate of profit without restoring the prior absolute margin trajectory. We credit a Q4 improvement while reducing next year’s recovery assumption.
How much of the backlog can ship next year?
Q: “I know you haven't given guidance, but I'm just curious of that backlog, how much of that backlog is convertible or shippable in 2027?”
— Nigel Coe, Wolfe Research
A: “Yeah. Nigel, just on the over of backlog, that's for 2027 and beyond, as Dave described, there's probably some backlog we're already building here for 2028 that could be over $1 billion at this point.”
— Chris Kuehn, EVP and CFO
Assessment: The clarification prevents treating over $8 billion as a 2027 commitment. Management supplies a useful outer-year component but no precise FY27 shipment schedule. The backlog supports our growth forecast without eliminating timing risk.
Where did pricing disappoint?
Q: “Just want to confirm, when you said the pricing in the third quarter was below expectations, was that both residential and commercial or just residential?”
— Andrew Obin, Bank of America
A: “Think of it really in the short-cycle businesses, Andrew. Think of, say, residential and transport were really the big drivers there.”
— Chris Kuehn, EVP and CFO
Assessment: The CEO separately added unitary, while the CFO confirmed positive commercial HVAC pricing. The discussion locates the shortfall in short-cycle mix and incentives rather than proving applied price erosion. It nevertheless leaves enterprise price/cost negative, so the distinction preserves the franchise thesis without repairing the earnings bridge.
Is residential growth borrowing from the next quarter?
Q: “Was there any pull forward ahead of anticipated price increases? Anything that you're managing before price increases?”
— Joe O'Dea, Vertical Research
A: “Joe, let me add, year-to-date sell in and sell through are roughly equivalent to each other. Inventory in the channel at the end of September was in very good position. That's very similar to where we saw it throughout each of the quarters this year. For the fourth quarter, in terms of our guide, we're expecting residential to be up in that high single-digit range.”
— Chris Kuehn, EVP and CFO
Assessment: The CEO denied pull-forward; the CFO supplied the stronger supporting observation, channel sell-through matching sell-in. This reduces inventory risk, though easier comparisons and refrigerant-related product mix still prevent equating sales growth with unit-demand acceleration.
How much of EMEA’s decline is the Middle East?
Q: “How much of the margin impact that you're seeing this year is coming just from the Middle East situation?”
— Joe Ritchie, Goldman Sachs
A: “So when you look at the dollars on a year-over-year basis, it's around $18 million of an operating income impact lower this year than last year. And of that, I'd say over 80% of it is really due to the deleverage in the Middle East in terms of the conflict.”
— Chris Kuehn, EVP and CFO
Assessment: The response quantifies the Q3 regional drag rather than the full-year question. It supports treating most of the regional shortfall as a known geographic exposure, but does not establish a recovery date or a new annual earnings bridge.
What They're NOT Saying
- The dollar price/cost deficit and rework cost: The call identifies mechanisms and pricing rates but not a complete dollar bridge. That limits confidence in how much of the Q3 shortfall can reverse without additional volume.
- A precise FY27 backlog shipment schedule: More than $8 billion spans multiple years, and cancellation or deposit terms remain undisclosed. Faster current conversion does not resolve concentration or future customer-site risk.
- Data-center services economics: Neither service attach nor the vertical’s profit contribution is separately sized. Our services thesis remains based on the broader installed base.
- The composition of accrued liabilities: Q3’s decline changes the direction of the cash debate but does not identify customer deposits. Strong FCF cannot by itself settle whether timing benefits will reverse.
- A bound on FY27 reinvestment costs: The 25%-plus leverage framework is reiterated, while supplier capacity improves only through H1 and Stellar continues to invest. The timing of profit normalization remains less certain than sales growth.
Market Reaction
TT entered the print at $448.47, up 15.2% year to date, 4.9% over twelve months and down 1.6% over thirty days. The S&P 500 had gained 13.1% year to date. The pre-print 52-week closing range was $376.43–$503.46: expectations were elevated relative to the market, but the shares were already below their peak.
On October 29 the stock opened at $421.70, a 6.0% decline, traded between $410.05 and $432.35, and closed at $431.10, down 3.9%. Volume of 2.9 million shares was 2.3 times the 30-day average. The S&P 500 fell 0.3%, leaving TT behind by roughly 3.6 percentage points.
The selloff is consistent with investors discounting weaker conversion of revenue into profit and an unchanged earnings outlook. Contemporary commentary emphasized those issues, but the price path cannot prove which disclosure caused each trade. Unlike July’s close near the session low, TT recovered materially from its opening and intraday lows; that recovery is consistent with some investors still valuing the backlog, although their motives cannot be established from prices alone. Our interpretation is a debate over the margin premium rather than evidence that the demand franchise has broken.
Street Perspective
Does slower bookings growth signal a cooling cycle?
Bull view: Large data-center projects make quarterly orders uneven, while all three regions retain book-to-bill above one and backlog continues to grow. Bear view: A shift from 37% to 20% organic bookings growth can precede a slower revenue cycle, especially in a concentrated equipment book. Our take: Current shipment acceleration and regional breadth give the bull case more support on demand. We would need cancellation or broader order weakness before treating the slowdown as a cycle reversal.
Can the margin setback be treated as temporary?
Bull view: Completed component rework, easier price comparisons and improving transport volumes support a sharp Q4 leverage recovery. Bear view: Pricing is weaker across short-cycle businesses, ordinary supply constraints extend into 2027 and the annual leverage target has already been cut. Our take: The bear case has the stronger twelve-month earnings argument. A discrete disruption has ended; the broader inflation and capacity imbalance has not. That distinction drives our forecast cut rather than a blanket rejection of management’s recovery plan.
Our Estimates & Valuation
| Analyst assumption | July view | Current view | Reason |
|---|---|---|---|
| FY26 reported revenue growth | About 11.5% | About 13.5% | Adopt raised revenue guide |
| FY26 adjusted EPS | $15.25 | $15.25 | Keep guide midpoint; tax shift cancels across quarters |
| FY26 organic operating leverage | Low twenties | Low twenties | Our caution now aligns with reduced guide |
| FY26 capex / revenue | 2.3% | About 2% | Revised company spending plan |
| FY27 organic revenue growth | About 9% | About 9% | Equipment backlog, services and transport support growth |
| FY27 reported revenue growth | About 10% | About 10% | Assume roughly one point net acquisition/FX contribution |
| FY27 adjusted operating margin improvement | 40–60 bps | About 20 bps | Slower supplier recovery and ongoing investment |
| FY27 diluted share reduction | About 1.5% | About 1.5% | Continued repurchases |
| FY27 adjusted EPS | $17.50 | $17.00 | Reduced operating recovery, no change to FY26 anchor |
Our FY26 revenue estimate is approximately $24.20 billion: 13.5% growth on the $21.322 billion FY25 base. Nine-month sales of $18.083 billion leave roughly $6.12 billion for Q4. For FY27, 10% reported growth yields approximately $26.62 billion. Assuming a roughly 18% FY26 adjusted operating margin and 20 basis points of FY27 expansion produces about $4.85 billion of adjusted operating profit, up roughly 11.2%. This is an analyst scenario, not company FY27 guidance.
An illustrative earnings bridge from $15.25 adds about $1.71 from that operating growth, about $0.25 from a 1.5% share reduction and subtracts roughly $0.21 for tax and other below-the-line normalization, arriving at $17.00. We assume a roughly 20% FY27 adjusted tax rate against management’s 19% FY26 outlook, with modest financing/other offsets. Relative to July, reducing the margin expansion assumption by approximately 30 basis points costs roughly $0.29 per share on $26.62 billion sales, an 80% after-tax conversion and about 219 million diluted shares; the remaining approximately $0.21 reduction allows for below-the-line normalization. The bridge makes clear that the sales thesis is intact while the earnings recovery is less generous.
At $431.10, TT trades at 28.3 times our FY26 estimate and 25.4 times FY27. We reduce the base valuation multiple to 27 times from 29 times on the same FY27 earnings period. This is an explicit reduction in the premium we are willing to pay after the failed enterprise-margin signpost, while retaining a premium for services and the visible order book. It still requires a modest rerating from today’s forward multiple; it is not a no-rerating case.
| Twelve-month scenario | FY27 adjusted EPS | P/E assumption | Value | Price return | Total return with $4.20 dividends |
|---|---|---|---|---|---|
| Bull | $18.25 | 30x | $547.50 | +27.0% | +28.0% |
| Base | $17.00 | 27x | $459.00 | +6.5% | +7.4% |
| Bear | $15.75 | 23x | $362.25 | -16.0% | -15.0% |
The $49 decline in base value from approximately $508 is mostly multiple risk: $0.50 lower EPS at the old 29 times costs $14.50, and two fewer multiple turns on $17.00 costs another $34.00. The bull case requires supplier normalization and stronger margin expansion with sustained backlog conversion; the bear case allows shipment delays and persistent price/cost pressure to hold earnings near this year’s level while the premium contracts further.
Twelve-month value: $459, implying 6.5% price upside and approximately 7.4% total return assuming the prior disclosed $4.20 annual dividend rate stays unchanged. We use an 8% S&P 500 total-return hurdle as an analyst assumption, not an index forecast sourced from the Street. A base return around that hurdle, against approximately 15% downside including dividends, no longer supports Outperform. The bull scenario remains meaningful, but it depends on the margin recovery that just failed its first explicit test.
Thesis Scorecard Post-Earnings
| Standing thesis point | Q3 verdict / standing tag | Evidence and consequence |
|---|---|---|
| Bull 1: Americas commercial HVAC applied franchise | Confirmed / ON TRACK | Applied revenue >60%; commercial HVAC demand remains strong |
| Bull 2: Services annuity | Confirmed / ON TRACK | Americas services +10%; global ex-Middle East >10%; no separate data-center attach disclosure |
| Bull 3: In-region manufacturing tariff moat | Challenged / AT RISK, unchanged | Lower-tier disruption shows limits of domestic assembly protection; no demonstrated relative share loss |
| Bull 4: Backlog conversion drives acceleration | Confirmed / ON TRACK | Organic sales +16%; over $8B of future-year backlog extends visibility |
| Bear 1: Growth is narrow | Challenged / CONTAINED | Residential and transport contribute; all regions grow organic sales and orders |
| Bear 2: Price/cost has turned | Confirmed / MATERIALIZING | Enterprise margin -40bps and full-year leverage target reduced |
| Bear 3: No valuation cushion | Strengthened / CONTAINED → EMERGING | Lower earnings and multiple assumptions reduce base upside despite a lower stock price |
| Bear 4: Purchased backlog dilutes quality | Challenged / CONTAINED | Organic bookings +20% versus reported +21%; no evidence acquisition-led orders dominate this quarter |
Overall: The demand thesis strengthened, but the investment thesis weakened because July’s upgrade required profit conversion as well as shipments. Of the four explicit quarterly signposts, applied growth exceeded the commitment, the gross-margin decline narrowed and buybacks accelerated; enterprise adjusted margin failed to expand. That last condition was a stated downgrade trigger, and strong revenue does not cancel it.
Action: Downgrade to Hold. We would reconsider Outperform if Q4 delivers the promised above-25% organic leverage, pricing improves toward the stated 1.5-point enterprise objective and FY27 guidance supports recovering margins without sacrificing investment. Persistent low-twenties leverage into 2027, a renewed full-year earnings reduction or broader backlog cancellations would move the case toward the bear scenario. The franchise deserves continued attention; the current return does not yet compensate for the margin uncertainty.